SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-012596
Filing Date
2023-02-17
Accepted
2023-02-17 08:20:33
Documents
18
Period of Report
2023-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea173877-8k_jasper.htm   iXBRL 8-K 47411
2 THIRD AMENDED AND RESTATED BYLAWS OF JASPER THERAPEUTICS, INC., EFFECTIVE AS OF ea173877ex3-1_jasper.htm EX-3.1 154129
3 PRESS RELEASE DATED FEBRUARY 17, 2023 (NEW BRIQUILIMAB AML MDS DATA) ea173877ex99-1_jasper.htm EX-99.1 20232
4 PRESS RELEASE DATED FEBRUARY 17, 2023 (APPOINTMENT OF VISHAL KAPOOR TO BOARD OF ea173877ex99-2_jasper.htm EX-99.2 11840
5 GRAPHIC ex99-1_001.jpg GRAPHIC 4900
6 GRAPHIC ex99-2_001.jpg GRAPHIC 4900
  Complete submission text file 0001213900-23-012596.txt   528274

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE jspr-20230216.xsd EX-101.SCH 4133
8 XBRL DEFINITION FILE jspr-20230216_def.xml EX-101.DEF 26833
9 XBRL LABEL FILE jspr-20230216_lab.xml EX-101.LAB 37093
10 XBRL PRESENTATION FILE jspr-20230216_pre.xml EX-101.PRE 25457
12 EXTRACTED XBRL INSTANCE DOCUMENT ea173877-8k_jasper_htm.xml XML 5986
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39138 | Film No.: 23640367
SIC: 2836 Biological Products, (No Diagnostic Substances)